Vista Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 2.50 | 1.87 | 3.23 |
| Operating Expense | 3.32 | 2.57 | 2.87 |
| Net Profit | -0.97 | -0.86 | 0.09 |
| Net Profit Margin | -38.80 | -45.99 | 2.79 |
| Earning Per Share | -0.16 | -0.15 | 0.02 |
| EBIDTA | -0.54 | -0.40 | 0.55 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 2.50 |
| Operating Expense | 3.32 |
| Net Profit | -0.97 |
| Net Profit Margin | -38.80 |
| Earning Per Share | -0.16 |
| EBIDTA | -0.54 |
| Effective Tax Rate | TBA |
Invest in Vista Pharmaceuticals Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 10.29 | 1.00 | 0.39 |
| Operating Expenses Annual | 13.60 | 5.45 | 1.66 |
| Operating Profit Annual | -3.24 | -4.05 | -1.10 |
| Interest Annual | 1.22 | 1.21 | 0.90 |
| Depreciation | 0.72 | 0.62 | 0.62 |
| Net Profit Annual | -4.51 | -5.66 | -0.89 |
| Tax Annual | -0.67 | -0.21 | -1.73 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 10.29 |
| Operating Expenses Annual | 13.60 |
| Operating Profit Annual | -3.24 |
| Interest Annual | 1.22 |
| Depreciation | 0.72 |
| Net Profit Annual | -4.51 |
| Tax Annual | -0.67 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.20 | 0.07 | 0.14 |
| Cash Flow from Operations | -4.91 | -1.71 | -0.99 |
| Cash Flow from Investing | -0.79 | -1.27 | -0.01 |
| Cash Flow from Financing | 5.59 | 3.11 | 0.94 |
| Cash Flow at the End | 0.09 | 0.20 | 0.07 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.20 |
| Cash Flow from Operations | -4.91 |
| Cash Flow from Investing | -0.79 |
| Cash Flow from Financing | 5.59 |
| Cash Flow at the End | 0.09 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | -31.29 | -392 | -282.05 |
| PBIT Margin (%) | -38.29 | -454 | -441.03 |
| PBT Margin (%) | -7.39 | -116 | 48.71 |
| Net PROFIT Margin (%) | -43.83 | -566 | -228.21 |
| Return On Networth / Equity (%) | TBA | TBA | TBA |
| Return On Networth /Employed (%) | TBA | TBA | TBA |
| Return On Assets (%) | -9.64 | -11.32 | -2.28 |
| Total Debt / Equity (X) | 0.23 | 0.31 | 0.34 |
| Asset Turnover Ratio (%) | 0.22 | 0.02 | 0.01 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | -31.29 |
| PBIT Margin (%) | -38.29 |
| PBT Margin (%) | -7.39 |
| Net PROFIT Margin (%) | -43.83 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -9.64 |
| Total Debt / Equity (X) | 0.23 |
| Asset Turnover Ratio (%) | 0.22 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 19.32 | 19.74 | 19.33 |
| Total Current Assets Annual | 23.40 | 23.75 | 23.56 |
| Non Current Assets Annual | 34.58 | 32.28 | 32.03 |
| Total Shareholders Funds Annual | 40.46 | 36.71 | 35.45 |
| Total Assets Annual | 57.98 | 56.03 | 55.59 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 19.32 |
| Total Current Assets Annual | 23.40 |
| Non Current Assets Annual | 34.58 |
| Total Shareholders Funds Annual | 40.46 |
| Total Assets Annual | 57.98 |
No Data Availabe
